GGrantIndex
Sort

40,608 grants matching prostate cancer

Hyperpolarized 13c NMR Studies of Prostate Cancer (RMI)

$383,111
University Of California San Francisco · R21 · FY2005 · EB

Improving prostate biopsy efficiency: The finasteride challenge test

$383,083
Javier Hernandez · University Of Texas Hlth Science Center · R01 · FY2014 · CA

Programmable DNA Binding Oligomers for Control of Transcription

$383,057
Peter B. Dervan · California Institute Of Technology · R01 · FY2011 · GM

Programmable DNA Binding Oligomers for Control of Transcription

$383,057
Peter B. Dervan · California Institute Of Technology · R01 · FY2012 · GM

Prostate stem cells and cancer stem cells

$383,054
Jonathan Vogel · Basic Sciences · Z01 · FY2007 · CA

GEI - Genome-Wide Association Studies

$383,013
Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

AR Gene Rearrangements and AR Signaling in Prostate Cancer

$382,974
Scott M. Dehm · University Of Minnesota · R01 · FY2024 · CA

Southwest Oncology Group

$382,959
Patrick J Stiff · Loyola University Chicago · U10 · FY2008 · CA

Molecular Link Between Metabolic Syndrome and Prostate Cancer

$382,955
Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2017 · CA

Disruption of AKT Pathway for Cancer Intervention

$382,942
Jin Q Cheng · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA

Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy

$382,941
David Gius · University Of Texas Hlth Science Center · R01 · FY2021 · CA

The Biology of Prostate Stem Cells - Resubmission - 1

$382,926
E Lynette Wilson · New York University School Of Medicine · R01 · FY2014 · CA

Role of Selenium in Development and Health

$382,855
Dolph Hatfield · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Winship Cancer Institute, Emory University

$382,850
Emory University · P20 · FY2005 · CA

Tissue Resource

$382,841
Victoria Gresik · Baylor College Of Medicine · P50 · FY2009 · CA

Project 3: Molecular basis for epigenome homeostasis by histone chaperone and acetyltransferase complexes

$382,839
Ronen Marmorstein · University Of Pennsylvania · P01 · FY2020 · AG

NOVEL MARKERS FOR PROSTATE CANCER DIAGNOSIS/PROGNOSIS

$382,832
Corixa Corporation · R44 · FY2001 · CA

Glutaminase I isoforms as personalized biomarkers of prostate cancer

$382,809
Jiaoti Huang · Duke University · R01 · FY2024 · CA

Advancement and Validation of Prostate Diffusion and Spectroscopic MRI

$382,754
Stephan E Maier · Brigham And Women'S Hospital · R01 · FY2013 · CA

The Therapeutic Potential, Pharmacology and Toxiciity of Promising Small-Molecule

$382,753
Kenneth J. Pienta · University Of Michigan At Ann Arbor · U19 · FY2007 · CA

Glucocorticoids & Vitamin D: Role In Anti-Tumor Effects

$382,661
Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA

Phase I/II trial of green tea and quercetin in docetaxel chemotherapy

$382,631
Piwen Wang · Charles R. Drew University Of Med & Sci · U54 · FY2024 · MD

Developmental Funds

$382,582
Ralph W. De Vere White · University Of California At Davis · P30 · FY2017 · CA

Mechanisms for GH action on epithelial cells

$382,500
Shlomo Melmed · Cedars-Sinai Medical Center · R01 · FY2021 · DK

INVESTIGATING THE ROLE OF AKT1 IN PROSTATE CANCER DEVELOPMENT THROUGH PHOSPHORYLATION-DEPENDENT REGULATION OF SKP2 STABILITY & ONCOGENIC FUNCTION

$382,500
Beth Israel Deaconess Medical Center, Inc. · · FY2009 · Department of the Army